Back to top

Image: Bigstock

Volatility Hits Tech Stocks, But Robotics & Automation Offer Growth

Read MoreHide Full Article

  • (1:30) - Tech Selloff: Is It Time To Panic?
  • (4:15) - Concerns Over Storage of Personal Information
  • (7:00) - Should You Be Avoiding FANG?
  • (11:05) - Who Will Lead The Way For Tech In 2018?
  • (13:40) - Episode Roundup: Podcast@Zacks.com

Maddy Johnson and Ryan McQueeney of the Zacks Friday Finish Line team are joined by Jeremie Capron, the director of research at Robo Global, for a special discussion about the tech sector’s recent volatility, whether investors should ditch FAANG stocks, and how smaller AI and robotics companies still present exciting growth opportunities.

Make sure to subscribe and leave the show a rating on Apple Podcasts!

ROBO Global is the creator of the ROBO Global® Robotics and Automation Index series, which provides comprehensive, transparent and diversified benchmarks representing the value chain of robotics, automation and artificial intelligence.

Jeremie was able to apply the beliefs of ROBO Global to demonstrate why the recent tech volatility—especially from the likes of Facebook , Amazon (AMZN - Free Report) , Netflix (NFLX - Free Report) , and Alphabet (GOOGL - Free Report) —points to near-term concerns rather than doubts about the future of technology.

To Jeremie and the rest of the ROBO Global team, it is clear that we have just scratched the surface of what can be done with automation and robotics, and that means we should continue to see exponential growth in the tech sector for years to come.

Listen to the show to hear more, and check out the ROBO Global Robotics and Automation Index ETF (ROBO - Free Report) for an investment strategy that seeks to capture these markets!

As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on Apple Podcasts.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>